IL-17/Th17 Pathway Is Activated in Acne Lesions

• Hanna-Leena Kelhälä,

  Affiliation Department of Dermatology, University of Oulu and Medical Research Center, Oulu University Hospital, Oulu, Finland

  ⨯
• Riitta Palatsi,

  Affiliation Department of Dermatology, University of Oulu and Medical Research Center, Oulu University Hospital, Oulu, Finland

  ⨯
• Nanna Fyhrquist,

  Affiliation Unit of Systems Toxicology, Finnish Institute of Occupational Health, Helsinki, Finland

  ⨯
• Sari Lehtimäki,

  Affiliation Unit of Systems Toxicology, Finnish Institute of Occupational Health, Helsinki, Finland

  ⨯
• Juha P. Väyrynen,

  Affiliation Department of Pathology, University of Oulu and Oulu University Hospital, Oulu, Finland

  ⨯
• Matti Kallioinen,

  Affiliation Department of Pathology, University of Oulu and Oulu University Hospital, Oulu, Finland

  ⨯
• Minna E. Kubin,

  Affiliation Department of Dermatology, University of Oulu and Medical Research Center, Oulu University Hospital, Oulu, Finland

  ⨯
• Dario Greco,

  Affiliation Unit of Systems Toxicology, Finnish Institute of Occupational Health, Helsinki, Finland

  ⨯
• Kaisa Tasanen,

  Affiliation Department of Dermatology, University of Oulu and Medical Research Center, Oulu University Hospital, Oulu, Finland

  ⨯
• Harri Alenius,

  Affiliation Unit of Systems Toxicology, Finnish Institute of Occupational Health, Helsinki, Finland

  ⨯
• Beatrice Bertino,

  Affiliation Research, Galderma R&D, Sophia Antipolis, France

  ⨯
• Isabelle Carlavan,

  Affiliation Research, Galderma R&D, Sophia Antipolis, France

  ⨯
• Bruno Mehul,

  Affiliation Research, Galderma R&D, Sophia Antipolis, France

  ⨯
• Sophie Déret,

  Affiliation Research, Galderma R&D, Sophia Antipolis, France

  ⨯
• Pascale Reiniche,

  Affiliation Research, Galderma R&D, Sophia Antipolis, France

  ⨯
• Philippe Martel,

  Affiliation Early Development, Galderma R&D, Sophia Antipolis, France

  ⨯
• Carine Marty,

  Affiliation Early Development, Galderma R&D, Sophia Antipolis, France

  ⨯
• Ulrike Blume-Peytavi,

  Affiliation Department of Dermatology and Allergy, Charite Universitätsmedizin, Berlin, Germany

  ⨯
• Johannes J. Voegel ,

  * E-mail: antti.lauerma@hus.fi (AL); johannes.voegel@galderma.com (JJV)

  Affiliation Research, Galderma R&D, Sophia Antipolis, France

  ⨯
•  [ ... ],
• Antti Lauerma

  * E-mail: antti.lauerma@hus.fi (AL); johannes.voegel@galderma.com (JJV)

  Affiliation Department of Dermatology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland

  ⨯
• [ view all ]
• [ view less ]